Interlinked key facts
as of Oct 2026- Operator of a medical technology company intended to address unmet healthcare needs.
- Interlinked is valued at approximately $42.0M as of Oct 2026 (last reported valuation).
- It has raised $5.2M; the latest was Later Stage VC in Feb 2025.
- Notable investors include European Innovation Council, European Commission, CVX Ventures, Stockholm Innovation & Growth, Swedish-American Chamber of Commerce - New York (SACCNY) — 14 tracked in total.
- Status: Privately Held (backing).
Interlinked's last reported valuation, Nov 2021. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Interlinked: the Monday email on marks, rounds and moves
Interlinked funding rounds
No funding rounds for Interlinked are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Interlinked
14+Interlinked valuation
Interlinked's last reported valuation was $42 million in Nov 2021. No priced round, secondary trade or fund mark has surfaced since.
Interlinked investors
14 investors are on record for Interlinked, including European Innovation Council, European Commission, CVX Ventures and Stockholm Innovation & Growth.
About Interlinked
Operator of a medical technology company intended to address unmet healthcare needs. The company specializes in needs-based innovations for health and medical care and its device protects intravenous catheters from harmful forces, otherwise leading to mechanical complications, enabling healthcare providers to reduce complications such as dislodgement as well as spill of infusion fluids and blood.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2016
- Employees
- 15
- Website
- interlinked.care/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.